CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease (Q34113001)

31 July 2017

1 reference

title

CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease (English)

1 reference

31 July 2017

0 references

0 references

0 references

1

Blennow K

1 reference

31 July 2017

2

Vanmechelen E

1 reference

31 July 2017

Hampel H

3

1 reference

31 July 2017

1 August 2001

1 reference

31 July 2017

Molecular Neurobiology

1 reference

31 July 2017

24

1 reference

31 July 2017

87-97

1 reference

31 July 2017

1-3

1 reference

https://scigraph.springernature.com/pub.10.1385/mn:24:1-3:087

31 July 2017

0 references

cites work

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

1 reference

12 December 2020

The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases

1 reference

12 December 2020

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

12 December 2020

Increased cerebrospinal fluid tau in patients with Alzheimer's disease

1 reference

12 December 2020

No increase in cerebrospinal fluid tau protein levels in patients with vascular dementia.

1 reference

12 December 2020

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

1 reference

12 December 2020

A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.

1 reference

12 December 2020

Decreased beta-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?

1 reference

12 December 2020

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

12 December 2020

Low frequency of post-lumbar puncture headache in demented patients

1 reference

12 December 2020

Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

1 reference

12 December 2020

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

12 December 2020

Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment.

1 reference

12 December 2020

Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.

1 reference

12 December 2020

1 reference

12 December 2020

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

1 reference

12 December 2020

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

12 December 2020

Cerebrospinal fluid A beta42 is increased early in sporadic Alzheimer's disease and declines with disease progression

1 reference

12 December 2020

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

1 reference

12 December 2020

Elevation of microtubule-associated protein tau in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

12 December 2020

Sensitivity, specificity, and stability of CSF-tau in AD in a community-based patient sample.

1 reference

12 December 2020

Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231.

1 reference

12 December 2020

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

12 December 2020

Mild cognitive impairment: clinical characterization and outcome

1 reference

12 December 2020

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

1 reference

12 December 2020

Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.

1 reference

12 December 2020

Cerebrospinal fluid tau protein shows a better discrimination in young old (<70 years) than in old old patients with Alzheimer's disease compared with controls.

1 reference

12 December 2020

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

1 reference

12 December 2020

1 reference

12 December 2020

Basic and clinical studies on the measurement of tau protein in cerebrospinal fluid as a biological marker for Alzheimer's disease and related disorders: multicenter study in Japan.

1 reference

12 December 2020

Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF

1 reference

12 December 2020

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

12 December 2020

Decreased Levels of Amyloid-beta 1-42 in Cerebrospinal Fluid of Creutzfeldt-Jakob Disease Patients

1 reference

12 December 2020

Cerebrospinal fluid tau protein levels in demented and nondemented alcoholics.

1 reference

12 December 2020

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

1 reference

12 December 2020

CSF phosphorylated tau protein and mild cognitive impairment: a prospective study.

1 reference

12 December 2020

Tau protein and the neurofibrillary pathology of Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

1 reference

12 December 2020

Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients.

1 reference

12 December 2020

Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease

1 reference

12 December 2020

Clinical-neuropathological correlations in Alzheimer's disease and related dementias

1 reference

12 December 2020

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

1 reference

12 December 2020

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

1 reference

12 December 2020

Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

1 reference

12 December 2020

Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease.

1 reference

12 December 2020

Both total and phosphorylated tau are increased in Alzheimer's disease

1 reference

12 December 2020

Total tau protein immunoreactivity in lumbar cerebrospinal fluid of patients with Alzheimer's disease

1 reference

12 December 2020

Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob disease

1 reference

12 December 2020

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

12 December 2020

Diagnostic accuracy of Alzheimer's disease: a clinicopathological study.

1 reference

12 December 2020

A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

1 reference

12 December 2020

Tau protein is a potential biological marker for normal pressure hydrocephalus

1 reference

12 December 2020

Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease.

1 reference

12 December 2020

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

1 reference

12 December 2020

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

1 reference

12 December 2020

Increased CSF tau protein in corticobasal degeneration.

1 reference

12 December 2020

Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.

1 reference

12 December 2020

Diagnostic accuracy of Alzheimer's disease: a neuropathological study.

1 reference

12 December 2020

Update on the dementia spectrum of depression

1 reference

12 December 2020

Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease.

1 reference

12 December 2020

Tau in cerebrospinal fluids: establishment of the sandwich ELISA with antibody specific to the repeat sequence in tau.

1 reference

12 December 2020

CSF levels of tau, beta-amyloid(1-42) and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

Tau and apo E in CSF: potential aid for discriminating Alzheimer's disease from other dementias.

1 reference

12 December 2020

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

1 reference

12 December 2020

Identifiers

DOI

10.1385/MN:24:1-3:087

1 reference

PubMed ID

11831556

Dimensions Publication ID

31 July 2017

1019682346

0 references

Fatcat ID

release_n3kms4epizay7dvlhpqxkqzqda

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n3kms4epizay7dvlhpqxkqzqda

24 November 2022

mapped directly with Wikidata item

PubMed ID

11831556

1 reference

PubMed ID

11831556